H.I.G. Capital is a global private equity and alternative assets investment firm with $42 billion of equity capital under management.
Business Model: B2B
Revenue: $7B
Employees: 501-1,000
Address: 1450 Brickell Avenue
City: Miami
State: FL
Zip: 33131
Country: US
H.I.G. Capital is an American global private equity and alternative assets investment firm with $37 billion of equity capital under management. The firm operates a family of private equity, growth equity, biohealth, real estate, credit/special situations, lending, and syndicated credit funds. H.I.G. Capital specializes in providing both debt and equity capital to small and mid-sized companies, utilizing an operationally focused/ value-added approach. H.I.G. currently operates a family of funds: &g; H.I.G.’s equity funds invest in management buyouts, recapitalizations, and corporate carve-outs of both profitable as well as underperforming manufacturing and service businesses. &g; H.I.G.’s debt funds invest in senior, unitranche, and junior debt financing to companies across the size spectrum, both on a primary (direct origination) basis, as well as on the secondary markets. H.I.G. is also a leading CLO manager, through its WhiteHorse family of vehicles, and manages a publicly traded BDC, WhiteHorse Finance. &g; Other H.I.G. funds invest in various real assets, including real estate and shipping.
Contact Phone:
+13053792322
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2006 | Nexidia | Series E | 13M |
2/2017 | Xtera | Post-IPO Equity | - |
6/2000 | eMedicine | Series A | - |
6/2019 | MX Technologies | Series B | 0 |
6/2013 | Holland Services | Private Equity Round | - |
11/2015 | IGM Resins | Debt Financing | 26.9M |
7/2000 | FedBid | Series A | 0 |
5/2021 | Homewerks Worldwide | Private Equity Round | - |
1/2013 | Correctional Medical Group Companies | Private Equity Round | - |
9/2008 | Epic Production Technologies | Private Equity Round | - |
10/2007 | Zilker Labs | Series D | 10M |
8/2015 | US MED | Venture Round | - |
7/2013 | Sorveteria Creme Mel Ltda | Private Equity Round | - |
4/2020 | MODERN LOGISTICS | Debt Financing | 65M |
10/2003 | LVL7 Systems | Series B | 15.8M |
5/2006 | Ideal Image | Private Equity Round | 16M |
6/2015 | Northwest Carpet | Venture Round | - |
12/2015 | Mr. Cat | Venture Round | - |
7/2003 | iVivity | Series B | 13M |
4/2000 | Savvion | Series A | 25M |
6/2001 | OmniCluster Technologies | Venture Round | 10M |
10/2009 | Quinnova Pharmaceuticals | Series B | 17.4M |
1/2004 | APS Healthcare | Private Equity Round | - |
1/2008 | Texas Honing | Private Equity Round | - |
9/2002 | LVL7 Systems | Series B | 0 |
6/2021 | Enseo | Private Equity Round | - |
12/2017 | Carlton Group Limited | Private Equity Round | - |
2/2000 | TeleCommute Solutions | Venture Round | 19M |
3/2016 | Halex Istar | Private Equity Round | - |
10/2010 | The Engine Group | Private Equity Round | 100.1M |
8/2018 | Sage Hospice | Private Equity Round | - |
4/2021 | Concord USA | Private Equity Round | - |
4/2017 | Barnet Dulaney Perkins | Private Equity Round | - |
11/2007 | Tranzyme | Venture Round | 20M |
12/2007 | REVShare | Series A | 20M |
6/2013 | Raymond Express International | Private Equity Round | - |
3/2022 | Lovett Care | Private Equity Round | - |
10/2013 | Lexmark Carpet Mills | Private Equity Round | - |
5/2007 | Insight Global | Private Equity Round | - |
11/2015 | Centerfield | Venture Round | - |
6/2017 | Trace3 | Private Equity Round | - |
10/2015 | LocationSmart | Venture Round | 0 |
6/2013 | Locaid | Series D | 0 |
10/2005 | AGEIA Technologies | Series C | 27.5M |
10/2004 | Scentric | Venture Round | 5.6M |
6/2001 | HealthSTAR Communications | Private Equity Round | - |
6/2018 | Grupo Meridional | Private Equity Round | - |
9/2015 | Go2mobi | Private Equity Round | - |
3/2021 | On Target Laboratories | Series B | 21M |
8/2004 | Avera Pharmaceutical | Series C | 0 |
2/2019 | Cuyana | Series C | 30M |
9/2018 | Clínica AMO | Private Equity Round | - |
6/2004 | NorthStar Systems International | Venture Round | 0 |
7/2004 | NeurAxon | Series A | 1.9M |
10/2019 | Circle Graphics | Private Equity Round | - |
2/2011 | CardioFocus | Series C | 0 |
1/2006 | HFI. | Private Equity Round | - |
6/2022 | Load One, LLC | Private Equity Round | - |
7/2006 | Alder Biopharmaceuticals | Series B | 16M |
4/2012 | Alder Biopharmaceuticals | Series D | 0 |
6/2001 | Captus Networks | Series B | 1.5M |
5/2014 | CardioFocus | Debt Financing | 0 |
4/2021 | Salary.com | Private Equity Round | 67M |
6/2008 | Funambol | Series B | 12.5M |
6/2020 | USALCO | Private Equity Round | - |
2/2004 | Inovys | Series C | 0 |
10/2012 | Funambol | Venture Round | 0 |
11/2015 | Ship Supply International | Venture Round | - |
4/2017 | Southwestern Eye Center | Private Equity Round | - |
7/2011 | Hart InterCivic | Private Equity Round | - |
7/2007 | Safe-Guard Products | Private Equity Round | - |
5/2019 | Riveron | Private Equity Round | - |
6/2018 | Eze Castle Integration | Private Equity Round | - |
8/2003 | Invistics | Series A | 2.5M |
9/2000 | Nexidia | Series A | 2M |
6/2012 | Locaid | Private Equity Round | 5.8M |
1/2005 | Invistics | Series B | 5M |
10/2007 | Altiris Therapeutics | Series B | 0 |
1/2010 | TRAKAmerica | Private Equity Round | - |
3/2003 | Lancope | Series B | 5M |
4/2006 | VIX | Series B | 5M |
4/2003 | RxStrategies | Series A | 0 |
5/2004 | iVivity | Series C | 26M |
9/2010 | NeurAxon | Debt Financing | 0 |
8/2007 | NeurAxon | Series B | 32M |
8/2007 | VIX | Series C | 30M |
3/2005 | Netifice Communications | Venture Round | 55M |
4/2002 | Lancope | Series A | 5.5M |
6/2021 | Cleo | Private Equity Round | - |
7/2021 | MISCOwater | Private Equity Round | - |
4/2004 | Lancope | Series C | 12.5M |
8/2015 | Milestone Technologies | Private Equity Round | 42.5M |
11/2005 | Locaid | Series A | 5M |
7/2008 | Gemin X Pharmaceuticals | Series C | 38M |
2/2011 | Locaid | Series C | 13M |
10/2003 | OncoGenex | Post-IPO Equity | 0 |
6/2000 | TheScientificWorld | Series A | 8M |
9/2006 | iVivity | Series C | 10M |
1/2021 | Madrid Content City | Private Equity Round | - |
1/2005 | HyperBranch Medical Technology | Series A | 6M |
11/2005 | HexaTech | Series A | 8.9M |
1/2007 | Funambol | Series B | 5.3M |
4/2006 | Scentric | Series A | 10.4M |
7/2003 | EG Technology | Series B | 0 |
11/2006 | FanLib | Series A | 3M |
10/2007 | Apollo Endosurgery | Series A | 11.5M |
9/2014 | No Zebra Network | Private Equity Round | - |
11/2022 | ThoughtFocus | Private Equity Round | - |
12/2010 | SpotX | Series A | 12M |
4/2014 | Office Total | Private Equity Round | - |
7/2021 | Suzy | Series D | 50M |
1/2006 | American Hardwood Industries | Private Equity Round | - |
1/2016 | Iconic Therapeutics | Series C | 40M |
8/2021 | The Bluebird Group | Private Equity Round | - |
11/2006 | Lancope | Venture Round | 1.6M |
10/2005 | Salmedix | Series C | 0 |
2/2012 | Apollo Endosurgery | Series B | 0 |
1/2004 | VistaScape | Series D | 10.5M |
10/2021 | 3Pillar Global | Private Equity Round | - |
11/2007 | Clarus Therapeutics | Series C | 8M |
9/2021 | Clarus Therapeutics | Post-IPO Equity | 25M |
7/2000 | Cellit | Venture Round | 0 |
2/2006 | EGT | Series C | 8.5M |
7/2009 | Suniva | Series C | 75M |
6/2007 | EG Technology | Series C | 0 |
2/2016 | A10 Capital | Private Equity Round | 75M |
10/2010 | Nexidia | Series F | 23M |
3/2021 | Augmedics | Series C | 36M |
6/2023 | Augmedics | Series D | 0 |
2/2005 | LVL7 Systems | Series C | 21M |
7/2017 | VIRTUS Data Centres | Debt Financing | - |
8/2015 | Art Wilson Co | Venture Round | - |
5/2021 | eHealth | Post-IPO Equity | 225M |
12/2009 | Triad Retail Media | Private Equity Round | - |
5/2006 | Zilker Labs | Series C | 8M |
2/2019 | Digital Ware | Private Equity Round | - |
2/2011 | Der Grüne Punkt | Private Equity Round | - |
5/2005 | Tranzyme | Series A | - |
4/2009 | VIX | Series D | 2.5M |
1/2021 | General Datatech | Private Equity Round | - |
1/2020 | Dimand | Private Equity Round | - |
6/2006 | Align Networks | Private Equity Round | - |
8/2007 | CYA Technologies | Series B | 3M |
6/2010 | The Higher Gear Group | Private Equity Round | - |
5/2017 | Ecore Group | Private Equity Round | - |
12/2003 | Nexidia | Series C | 7.5M |
1/2002 | Nexidia | Series B | 8.5M |
10/2002 | Savvion | Series B | 21.7M |
12/2020 | KM2 Solutions | Private Equity Round | - |
11/2006 | Quinnova Pharmaceuticals | Series A | 13.6M |
10/2021 | Zerigo Health | Series B | 0 |
11/2012 | Vertice 360 Servicios Audiovisuales | Private Equity Round | - |
4/2019 | Medusind Solutions | Corporate Round | - |
6/2022 | Load One, LLC | Private Equity Round | - |
3/2022 | Lovett Care | Private Equity Round | - |
10/2021 | 3Pillar Global | Private Equity Round | - |
10/2021 | Zerigo Health | Series B | 0 |
9/2021 | Clarus Therapeutics | Post-IPO Equity | 0 |
8/2021 | The Bluebird Group | Private Equity Round | - |
7/2021 | Suzy | Series D | 0 |
7/2021 | MISCOwater | Private Equity Round | - |
6/2021 | Enseo | Private Equity Round | - |
6/2021 | Cleo | Private Equity Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|